Study of risk factors and prevalence of invasive candidiasis in a tertiary care hospital

Indian Journal of Critical Care Medicine

Volumn 11, Issue 2, 2007, Pages 67-73

  Chowta, Mukta ^a   Adhikari, Prabha ^a   Rajeev, A ^a   Shenoy, Ashok ^a  

^a KASTURBA MEDICAL COLLEGE   (India)

Author keywords

C. albicans; Candidiasis; Human immunodeficiency virus infection; Risk factors

Indexed keywords

ADULT; ANTIBIOTIC THERAPY; ARTICLE; ASCITES FLUID; BLOOD CULTURE; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDEMIA; CANDIDIASIS; CATHETER INFECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE PREDISPOSITION; FEMALE; HOSPITAL INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTRAVENOUS CATHETER; MALE; MORTALITY; PREVALENCE; RISK ASSESSMENT; SCREENING; SPUTUM CULTURE; TERTIARY HEALTH CARE; TREATMENT OUTCOME; URINE CULTURE;

EID: 34447644759     PISSN: 09725229     EISSN: None     Source Type: Journal    
DOI: 10.4103/0972-5229.33388     Document Type: Article

References (30)

1. Rangel-Frausto MS, Wiblin T, Blumberg HM, Saiman L, Patterson J, Rinaldi M, et al. National epidemiology of mycoses survey (NEMIS): Variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis 1999;29:253-8.
2. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Hospital-acquired candidemia. The attributable mortality and excess length of stay. Arch Intern Med 1988;148:2642-5.
3. Pfaller MA. Nosocomial candidiasis: Emerging species reservoir and modes of transmission. Clin Infect Dis 1996;22:S89-94.
4. Pittet D, Wenzel RP. Nosocomial blood stream infection. Secular trends in rates, mortality, and contribution to total hospital deaths. Arch Intern Med 1995;155:1177-84.
5. Wingard JR. Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin Infect Dis 1995;20:115-25.
6. Bross J, Talbot GH, Maislin G, Hurwitz S, Strom BL. Risk factors of nosocomial candidemia: A case- control study in adult without leukemia. Am J Med 1989;87:614-20.
7. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Risk factors for hospital-acquired candidemia: A matched case control study. Arch Intern Med 1989;149:2349-53.
8. Lecciones JA, Lee JW, Navarro EE, Witebsky FG, Marshall D, Steinberg SM, et al. Vascular catheter associated fungemia in patients with cancer: Analysis of 150 episodes. Clin Infect Dis 1992;14:875-83.
9. Karabinis A, Hill C, Leclercq B, Tancrede C, Baume D, Andremont A. Risk factors for candidemia in cancer patients: A case control study. J Clin Microbiol 1988;26:429-32.
10. Kao AS, Brandt ME, Pruitt WR, Conn LA, Perkins BA, Stephens DS, et al. The Epidemiology of candidemia in Two United States Cities: Results of a population-based active surveillance. Clin Infect Dis 1999;29:1164-70.
11. Rees JR, Pinner RW, Hajjeh RA, Brandt ME, Reingold AL. The epidemiological features of invasive mycotic infections in the San Francisco Bay area, 1992-1993: Results of population-based laboratory active surveillance. Clin Infect Dis 1998;27:1138-47.
12. Petrosillo N, Viale P, Nicastri E, Arici C, Bombana E, Caella A, et al. Nosocomial blood stream infections among human immuno-deficiency virus infected patients: Incidence and risk factors. Clin Infect Dis 2002;34:677-85.
13. Launay O, Lortholary O, Bouges-Michel C, Jarrousse B, Bentata M, Guillevin L. Candidemia: A nosocomial complication in adults with late-stage AIDS. Clin Infect Dis 1998;26:1134-41.
14. Dato VM, Dajani AS. Candidemia in children with central venous catheters: Role of catheter removal and amphotericin B therapy. Pediatr Infect Dis 1990;9:303-14.
15. Edwards JE Jr, Bodey GP, Bowden RA, Buchner T, de Pauw BE, Filler SG, et al. International conference for the development of consensus on the management and prevention of severe candidal Infections. Clin Infect Dis 1997;25:43-59.
16. Nucci M, Colombo Al, Silveira F, Richmann R, Saloma R, Branchini ML, et al. Risk factors for death in patients with candidemia. Infect Control Hosp Epidemiol 1998;19:846-50.
17. Silvestri L, delaCal MA, Von Saene HK, et al. Management of coagulase-negative staphylococcal, enterococcal and fungal problem in the intensive care unit. In: Von Saene HK, Silvestri L, dela Cal MA, editors. Infection control in the intensive care unit. Springer-Verlag Italia: Milan; 1998. p. 341-50.
18. van Saene R, Fairclough S, Petros A. Broad and narrow spectrum antibiotics: A different approach. Clin Microbiol Infect 1998;4:56-7.
19. Hope W, Morton A, Eisen DP. Increase in prevalence of nosocomial non-Candida albicans Candidaemia and the association of Candida krusei with fluconazole use. J Hosp Infect 2002;50:56-65.
20. Borg-von Zeppelin M, Eiffert H, Kann M, Ruchel R. Changes in the spectrum of fungal isolates: Results from clinical specimens gathered in 1987/88 compared with those in 1991/92 in the university of Gottingen, Germany. Mycoses 1993;36:247-53.
21. Abi-Said D, Anaissie E, Uzun O, Raad I, Pinzcowski H, Vartivarian S. The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis 1997;24:1122-8.
22. Rees JR, Pinner RW, Hajjeh RA, Brandt ME, Reingold AL. The epidemiological features of invasive mycotic infections in the San Francisco Bay area, 1992-1993: Results of population-based laboratory active surveillance. Clin Infect Dis 1998;27:1138-47.
23. Diekema DJ, Messer SA, Brueggemans AB, Coffman SL, Doern GV, Herwaldt LA, Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study. J Clin Microbiol 2002;40:1298-302.
24. Sandven P, Bevanger L, Digranes A, Gaustad P, Haukland HH, Steinbakk M. Constant low rate of fungemia in Norway, 1991 to 1996. J Clin Microbiol 1998;36:3455-9.
25. Leleu G, Aegerter P, Guidet B; College des Utilisateurs de Base de Donnees en Reanimation. Systemic candidiasis in intensive care units: A multicentre, matched cohort study. J Crit Care 2002;17:168-75.
26. Gudlauqsson O, Gillespie S, Lee K, Vande Berg J, Hu J, Messer S, et al. Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis 2003;37:1172-7.
27. Rex JH, Walsh TJ, Sobel JD, Filler SG, Pappas PG, Dismukes WE, et al. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America. Clin Infect Dis 2000;30:666-78.
28. Maschmeyes G, Ruhnke M. Update on antifungal treatment of invasive Candida and Aspergillus infection. Mycoses 2004;47:263-76.
29. Denning DW. Echinocandins: A new class of antifungals. J Antimicrob Chemother 2002;49:889-91.
30. Slavin MA, Osborne B, Adams R, Levenstein MJ, Schoch HG, Feldman AR, et al. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation-a prospective, randomized, double-blind study. J Infect Dis 1995;171:1545-52.